VistaGen Therapeutics
VTGN
$4.62
Share price
2.67%
Change (1 day)
3,453.85%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - P/B ratio
P/B ratio as of May 2024 : 1.01
According to VistaGen Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.01.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
VistaGen Therapeutics - P/B ratio (from 2011 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.13 | 9.33% |
| 2022-12-31 | 1.03 | -78.84% |
| 2021-12-31 | 4.87 | 71.66% |
| 2020-12-31 | 2.84 | -157.99% |
| 2019-12-31 | -4.89 | -117.77% |
| 2018-12-31 | 27.5 | 1061% |
| 2017-12-31 | 2.37 | -80.37% |
| 2016-12-31 | 12.1 | -207.2% |
| 2015-12-31 | -11.3 | 1678.23% |
| 2014-12-31 | -0.6334 | -22.06% |
| 2013-12-31 | -0.8127 | -39.47% |
| 2012-12-31 | -1.34 | -86.96% |
| 2011-12-31 | -10.3 | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.82 | 178.37% | 🇺🇸 USA |